Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
18.3 USD | +8.44% | +3.59% | +104.38% |
Financials (USD)
Sales 2024 * | 1.22B | Sales 2025 * | 1.53B | Capitalization | 3.63B |
---|---|---|---|---|---|
Net income 2024 * | 39M | Net income 2025 * | 68M | EV / Sales 2024 * | 2.79 x |
Net cash position 2024 * | 217M | Net cash position 2025 * | 418M | EV / Sales 2025 * | 2.1 x |
P/E ratio 2024 * |
104
x | P/E ratio 2025 * |
57.2
x | Employees | 1,046 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 83.13% |
Latest transcript on Hims & Hers Health, Inc.
1 day | +6.63% | ||
1 week | -9.25% | ||
Current month | +34.72% | ||
1 month | +35.04% | ||
3 months | +25.69% | ||
6 months | +104.11% | ||
Current year | +89.66% |
Managers | Title | Age | Since |
---|---|---|---|
Andrew Dudum
CEO | Chief Executive Officer | 35 | 21-01-19 |
Oluyemi Okupe
DFI | Director of Finance/CFO | 38 | 22-01-23 |
Patrick Carroll
CTO | Chief Tech/Sci/R&D Officer | 66 | 18-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Delos Cosgrove
BRD | Director/Board Member | 83 | 21-01-19 |
Director/Board Member | 41 | 17-09-30 | |
Alex Bard
BRD | Director/Board Member | 49 | 21-01-19 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.95% | 11 M€ | -6.03% | - | |
0.02% | 234 M€ | +9.05% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-28 | 18.23 | +8.00% | 4 593 698 |
24-05-24 | 16.88 | +6.63% | 10,022,632 |
24-05-23 | 15.83 | -2.10% | 11,200,598 |
24-05-22 | 16.17 | -7.92% | 16,267,107 |
24-05-21 | 17.56 | -5.59% | 21,745,834 |
Delayed Quote Nyse, May 24, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+89.66% | 3.63B | |
-46.73% | 1.95B | |
+78.57% | 584M | |
+12.60% | 485M | |
-26.62% | 91.48M |
- Stock Market
- Equities
- HIMS Stock